GlassScriptPhysician profile
Ayyash Yousef Melhem
NPI 1902044993
$1,112.39
in general payments reported to CMS, 2019-2025
17 companies · $49.73 in 2025
The $49.73 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $219 · 2021: $119 · 2022: $108 · 2023: $269 · 2024: $12.25 · 2025: $49.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $209.23 | 2019-2023 | Cardiomems |
| Cardiovascular Systems INC. | $158.08 | 2019 | |
| Novartis Pharmaceuticals Corporation | $133.25 | 2020-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.07 | 2019-2025 | Lifevest |
| Cook Medical LLC | $94.37 | 2019-2020 | |
| Pfizer INC. | $89.28 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $64.10 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $63.92 | 2023 | Assure Wcd |
| Amgen INC. | $56.09 | 2019-2025 | Repatha |
| Davol INC. | $38.93 | 2023 | Progel Applicator Spray Tips |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.24 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.61 | 2023 | |
| Angiodynamics, INC. | $14.06 | 2019 | |
| Boston Scientific Corporation | $14.05 | 2025 | Cds - Mct/Cem Monitoring |
| Merck Sharp & Dohme LLC | $13.87 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thrombolex, INC. | $12.25 | 2024 | Bashir Endovascular Catheter |
| Actelion Pharmaceuticals US, INC. | $11.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayyash Melhem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.